Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sensor protein QseC is a membrane-bound histidine sensor kinase that serves as a critical component of the QseBC two-component signaling system in various Gram-negative bacteria, including Escherichia coli and Salmonella [1, 4]. It acts as a bacterial adrenergic receptor, integrating interkingdom signaling by sensing both the bacterial autoinducer-3 (AI-3) and host stress hormones like epinephrine and norepinephrine [6, 7]. Upon activation, QseC undergoes autophosphorylation and transfers the phosphate group to the response regulator QseB, which then coordinates the expression of virulence factors, motility genes, and biofilm formation [4, 15]. Because QseC is conserved across many pathogens and is essential for pathogenesis but not for bacterial growth, it has emerged as a promising target for anti-virulence therapies [1, 5]. Small molecule inhibitors like LED209 have been developed to allosterically modify QseC, effectively 'disarming' the bacteria without exerting the strong selective pressure for resistance typically seen with traditional antibiotics [1, 12]. This approach offers a novel strategy to combat multi-drug resistant infections by targeting the pathogen's ability to cause disease rather than its survival [3, 4]. Research has shown that QseC inhibition can attenuate virulence in animal models of infection, such as rabbit and mouse models, without causing toxicity to the host [1, 13]. Furthermore, QseC also possesses phosphatase activity that is necessary for dephosphorylating QseB to maintain proper regulation of gene expression [16, 17].
LED209 acts as a prodrug that allosterically modifies QseC to inhibit its autophosphorylation and subsequent activation of virulence genes; it also blocks the binding of host catecholamines and bacterial AI-3 signals [1, 2, 12].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sensor protein QseC (QseC) (QseC).